https://medicalxpress.com/news/2023-05-major-brain-tumors-blocking-functions.html logotype Topics Conditions * Week's top * Latest news * Unread news * Subscribe [ ] Science X Account [ ] [ ] [*] Remember me Sign In Click here to sign in with or Forget Password? Not a member? Sign up Learn more * Addiction * Alzheimer's disease & dementia * Arthritis & Rheumatism * Attention deficit disorders * Autism spectrum disorders * Biomedical technology * Cardiology * Dentistry * Diabetes * Diseases, Conditions, Syndromes * Endocrinology & Metabolism * Gastroenterology * Genetics * Gerontology & Geriatrics * Health * Health informatics * HIV & AIDS * Immunology * Inflammatory disorders * Medical economics * Medical research * Medications * Neuroscience * Obstetrics & gynaecology * Oncology & Cancer * Ophthalmology * Other * Overweight & Obesity * Parkinson's & Movement disorders * Pediatrics * Psychology & Psychiatry * Radiology & Imaging * Sleep disorders * Sports medicine & Kinesiology * Surgery * Vaccination * Asthma * Breast cancer * Cardiovascular disease * Chronic obstructive pulmonary disease * Colon cancer * Coronary artery disease * Dementia * Depression * Heart attack * Heart disease * High blood pressure * Influenza * Kidney disease * Leukemia * Lung cancer * Malaria * Melanoma * Multiple sclerosis * Myocardial infarction * Ovarian cancer * Post traumatic stress disorder * Rheumatoid arthritis * Schizophrenia * Skin cancer * Stroke * Type 2 diabetes * Full List >> [INS::INS] * * share this! * 122 * 27 * Share * Email 1. Home 2. Oncology & Cancer 1. Home 2. Neuroscience * * * --------------------------------------------------------------------- May 24, 2023 Editors' notes This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility: fact-checked peer-reviewed publication trusted source proofread Major progress in curing brain tumors by blocking certain functions in cells with a docked molecule by University of Gothenburg Major progress in curing brain tumours The researchers' molecule Z4P inhibits one of the mechanisms that regulate protein production in a cancer cell. This inhibition causes the cancer cell to die. Three pictures show the spread of the tumor after 20 days of treatment on mice. Control: Untreated tumor. TMZ: Follow-up treatment solely with chemotherapy. Combo: Combination treatment with chemotherapy and the inhibitor Z4P. Credit: Molecule image: X. Guillory, Photos from animal studies: D. Pelizzari-Raymundo. Researchers at the University of Gothenburg, working with French colleagues, have successfully developed a method able to kill the aggressive brain tumor glioblastoma. By blocking certain functions in the cell with a docked molecule, the researchers cause the cancer to die of stress. Cancer cells, especially those that form aggressive tumors, are in one way or another out of control and live a very stressful existence. To manage this stress, the cancer cells hijack mechanisms that the healthy cells use to regulate protein production and process the surplus proteins that they create. Without these hijacked mechanisms, the cancer cell would die. "We have now succeeded in stopping this hijacking by inserting a specially developed molecule in the cells that inhibits one of these hijacked adaptive mechanisms in the cancer cells. This causes the cancer to self-destruct," says Leif Eriksson, professor of physical chemistry at the University of Gothenburg. Swedish-French collaboration Leif Eriksson's group has worked with a research group at INSERM in Rennes, France. Using super computers and advanced simulations, the researchers developed a version of the molecule that can also pass through the blood-brain barrier that protects brain tissue. They have presented their findings in the journal iScience. The breakthrough applies to glioblastoma brain tumors. These make up about 45 percent of all brain tumors and around 400 Swedes are diagnosed with glioblastomas every year. For the EU as a whole, there are 19,000 cases annually. Currently, the prognosis for malignant glioblastomas is very bad. Only a few percent survive five years after diagnosis and treatment. "Today, cancer treatment consists of surgery, radiation and chemotherapy. Unfortunately, all cancer cells are not killed and the tumor returns. Once the cancer relapse, the tumor cells have often spread and developed resistance," Leif Eriksson. Studying how it can be used with other cancers Studies with the new method have shown very promising results. The researchers saw that a combination treatment with the new substance and chemotherapy was enough to completely kill the tumors while also preventing relapse. Since the tumors were stressed to death, all cancer cells disappeared, and in animal experiments with mice there was no cancer relapse after 200 days. In comparative experiments with just chemotherapy, the brain tumors relapsed after 100 days and grew rapidly. "These are the first clear results with brain tumors that can lead to a treatment which completely avoids surgery and radiation. We have also begun studying the use of our substance on other aggressive tumor forms like pancreatic cancer, triple-negative breast cancer and certain lever cancers," says Eriksson. There are other types of brain tumors that develop differently than glioblastomas. This new method does not work with these forms of cancer. No side effects Current treatments for brain tumors often have severe side effects. With this new treatment, the researchers have not yet seen any side effects with the substance. The treated animals maintained weight, had no apparent changes in behavior and there was no sign of impact on the liver. While more in-depth studies are needed, extensive cell tests have shown that the substance is non-toxic for healthy cells even at very high doses. Research on this molecule will now continue. There is still much to do, such as optimizing the treatment procedure and additional animal experiments. But Leif Eriksson hopes and believes that it should go relatively quickly to get the pharmaceutical into clinical treatment. "It largely depends on whether funding comes in that allows taking the different steps as smoothly as possible. If I'm optimistic, perhaps it might take five years. That's a short timeframe, but at the same time glioblastomas are nearly 100 percent fatal, so any improvement in medical care is major progress," says Eriksson. More information: Diana Pelizzari-Raymundo et al, A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatment, iScience (2023). DOI: 10.1016/j.isci.2023.106687 Journal information: iScience Provided by University of Gothenburg Citation: Major progress in curing brain tumors by blocking certain functions in cells with a docked molecule (2023, May 24) retrieved 27 May 2023 from https://medicalxpress.com/news/ 2023-05-major-brain-tumors-blocking-functions.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only. --------------------------------------------------------------------- Explore further New radiation therapy delays brain cancer regrowth, protects healthy tissue --------------------------------------------------------------------- 153 shares * Facebook * Twitter * Email Feedback to editors * Featured * Last Comments * Popular Causal association found between evening social media use and delayed sleep May 26, 2023 0 Whether causing the common cold or COVID-19, coronaviruses deploy key enzymes to elude human immune response May 26, 2023 0 Heart donors with COVID-19 found to confer higher mortality risk to those receiving new hearts May 24, 2023 0 Mpox vaccine found to be protective by CDC May 22, 2023 0 A global effort to identify critical illness in some COVID-19 patients highlights genetic risk, potential treatments May 19, 2023 0 --------------------------------------------------------------------- [gif] New study uncovers role of previously unknown protein in obesity and diabetes May 26, 2023 [gif] Gene therapy rescues hearing for the first time in aged mouse models May 26, 2023 [gif] Innovative endoscopic imaging system can detect multiple fluorescent tracers May 26, 2023 [gif] Researchers show that immunoglobulin A fine-tunes the body's interactions with microbes May 26, 2023 [gif] Exploring the mechanisms behind swallowing May 26, 2023 [gif] Causal association found between evening social media use and delayed sleep May 26, 2023 [gif] Teenage girls are more sensitive to the anxiety of other girls, finds study May 26, 2023 [gif] How Botox enters brain cells, a discovery that could save lives May 26, 2023 [gif] Five types of heart failure identified using AI tools May 26, 2023 [gif] State policies can boost use of anti-opioid medication May 26, 2023 [INS::INS] * Related Stories [gif] New radiation therapy delays brain cancer regrowth, protects healthy tissue Sep 19, 2022 [gif] Technique for tracking resistant cancer cells could lead to new treatments for relapsing breast cancer patients Dec 20, 2022 [gif] Zapping brain cancer with long needles opens door to new treatments Nov 25, 2022 [gif] New method used to study how cancer cells are organised Sep 20, 2021 [gif] Enzyme responsible for dangerous properties of brain tumor stem cells Jul 11, 2019 [gif] A stem cell protein facilitates relapse of pediatric brain tumors Oct 28, 2022 * Recommended for you [gif] Exploring the mechanisms behind swallowing May 26, 2023 [gif] Research team develops new system for imaging and treating tumors May 26, 2023 [gif] Rethinking the protein inhibitor approach to cancer therapy May 26, 2023 [gif] Gas-releasing adjuvant improves efficacy of photothermal therapy for cancer May 26, 2023 [gif] How Botox enters brain cells, a discovery that could save lives May 26, 2023 [gif] The brain's protein-destruction machine learns new tricks at synapses, potential target for neurological treatments May 25, 2023 Load comments (0) Let us know if there is a problem with our content Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines). Please select the most appropriate category to facilitate processing of your request [-- please select one -- ] [ ] [ ] [ ] [ ] [ ] Your message to the editors [ ] Your email (only if you want to be contacted back) [ ] Send Feedback Thank you for taking time to provide your feedback to the editors. Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages. E-mail the story Major progress in curing brain tumors by blocking certain functions in cells with a docked molecule Your friend's email [ ] Your email [ ] [ ] I would like to subscribe to Science X Newsletter. Learn more Your name [ ] Note Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form. [ ] [ ] [ ] [ ] [ ] [ ] [ ] Your message [ ] Send Newsletter sign up Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we'll never share your details to third parties. [ ] Subscribe More information Privacy policy Phys.org Phys.org Daily science news on research developments and the latest scientific innovations Tech Xplore Tech Xplore The latest engineering, electronics and technology advances ScienceX Science X The most comprehensive sci-tech news coverage on the web Newsletters [ ] Subscribe Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox Follow us * * * * * Top * Home * Search * Mobile version * Help * FAQ * About * Contact * Science X Account * Sponsored Account * Newsletter * Archive * Android app * iOS app * RSS feeds * Push notification (c) Medical Xpress 2011 - 2023 powered by Science X Network Privacy policy Terms of use Medical Disclaimer Your Privacy This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. By using our site, you acknowledge that you have read and understand our Privacy Policy and Terms of Use. I'm OK with that Cookie options E-mail newsletter [ ] Subscribe Follow us * * * * It appears that you are currently using Ad Blocking software. What are the consequences? x Quantcast